Recent Drug Approvals in Acute Myeloid Leukemia (AML)

Part of the Oncology Grand Rounds Series - Kelly Norsworthy, MD reviews the timeline for FDA approvals of AML drugs and discusses the requirements for approval. Dr. Norsworthy explains the compassionate use and how expanded access allows patients with serious of life-threatening conditions to be treated with investigational therapies. 

 


Created by

Johns Hopkins Greater Washington Area

Related Presenters